Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142877 · ClinicalTrials.gov registry record · NA
Effects of Social Media Use on Young Adults' E-Cigarette Use
A NA study of Electronic Cigarette Use, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06142877: Recruiting NA study of Electronic Cigarette Use, sponsored by University of Oklahoma.
NCT06142877 is a NA study of Electronic Cigarette Use that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 200 participants, roughly in line with the 199-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142877, a NA study of Electronic Cigarette Use, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are: * Does reducing social media use change young adults' e-cigarette use? * Does reducing social media use change things such as young adults' mental health and what they see on social media? Participants will complete surveys and submit screenshots showing how much time they spend on social media. Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.
Conditions Studied
Interventions
- BEHAVIORAL Social Media Use Reduction
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
What NCT06142877 shows while recruiting
NCT06142877 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 199-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target.
The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 1 intervention - of which Social Media Use Reduction is the first listed.
NCT06142877 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06142877 about?
NCT06142877 is a clinical study titled "Effects of Social Media Use on Young Adults' E-Cigarette Use". The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are: * Does reducing social media use change young adults' e-cigarette use? * Does reducing social media use change things such as...
What is the current status of trial NCT06142877?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-12-04. Estimated completion is 2025-03-01.
What conditions does trial NCT06142877 study?
This clinical trial studies the following conditions: Electronic Cigarette Use.
What interventions are being tested in trial NCT06142877?
The interventions under investigation include: Social Media Use Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06142877?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06142877 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06142877's enrollment target sits among peer trials
200 7th of 15 higher than 9 of 15 other Electronic Cigarette Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Electronic Cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
RECRUITING · NA
-
Effect of Menthol on ENDS Users' Addiction and Exposure
RECRUITING · NA
-
Developing and Testing Health Warning Labels on the ENDS Device
RECRUITING · NA
-
Development of UP2UTobacco for High School Youth
ACTIVE NOT RECRUITING · NA
-
PACE Vape Messaging Study
COMPLETED · NA
-
Assessing Electronic Cigarette Nicotine Flux
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI